|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.03 USD | -1.08% |
|
-17.72% | -22.43% |
| Jan. 14 | NovoCure Limited Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 09:45 AM | |
| Jan. 12 | NovoCure Reports Rise in Q4 Preliminary Revenue | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Medical Equipment
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.12B | - | - | - | ||
| 13.28B | |||||
| 12.57B | - | - | - | - | - |
| 7.24B | - | - | |||
| 6.19B | |||||
| 5.7B | - | - |
- Stock Market
- Equities
- NVCR Stock
- Charts NovoCure Limited
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
